about
Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromesCytogenetic and molecular abnormalities in chronic myelomonocytic leukemiaChronic neutrophilic leukemia: a clinical perspectiveTherapy-Related Myeloid NeoplasmsChronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and managementEmerging patterns of somatic mutations in cancerEvaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literatureClinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasmsA novel BCR-ABL1 fusion gene with genetic heterogeneity indicates a good prognosis in a chronic myeloid leukemia case.ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia.Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantationTet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells.Clinical and genetic predictors of prognosis in myelodysplastic syndromes.Molecular features of early onset adult myelodysplastic syndromePrioritization of neurodevelopmental disease genes by discovery of new mutations.From the Biology of PP2A to the PADs for Therapy of Hematologic MalignanciesRefining analyses of copy number variation identifies specific genes associated with developmental delayDeep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria.SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.PRPF8 defects cause missplicing in myeloid malignancies.Clonal evolution in myelodysplastic syndromesPathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease.Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemiaMutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy.The molecular basis of myeloid malignancies.SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS.Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia.Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.Overlapping SETBP1 gain-of-function mutations in Schinzel-Giedion syndrome and hematologic malignancies.Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes.Myelodysplastic syndromes, version 2.2015Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia developmentRelapse after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Analysis of Late Relapse Using Comparative Karyotype and Chromosome Genome Array TestingClonality of neutrophilia associated with plasma cell neoplasms: report of a SETBP1 mutation and analysis of a single institution series.An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms.Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS.The multi-omic landscape of transcription factor inactivation in cancer.BRCC3 mutations in myeloid neoplasms.Peripheral blood cell-free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes.Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.
P2860
Q26752940-07329C0A-C58F-4498-8088-8128F5D0422BQ26768600-767C5348-5F19-4760-8C0C-AA13C8577B68Q26781167-C1791E5A-DABA-474D-8092-C3C3C0F96213Q26799786-56E333CA-F4AF-4002-9377-D94C83CE5BBFQ27009366-F381B9DE-963F-465F-9F1C-15655E33CCE1Q27014126-A53A428C-AC2B-44E7-8B89-CA10158EE143Q28083489-7F8FA1E3-C2B8-4AE0-87FF-674E82BE6252Q29039802-6E412633-73DA-4F7E-919D-2A89FB53E727Q30152631-FAE8231D-E930-4461-84F1-97C29AF21F75Q33421772-B01A0B00-A5A7-4FE1-931C-4A4063D3C94CQ33615619-17B7351F-6E13-4990-AD2E-E443EC3F9165Q33629603-50D237A1-E1BA-4755-A339-43E3F8DF67B5Q33695906-CA002185-DBC6-4E71-8309-B7F2FAFDC8FAQ33746718-6255F5E2-7481-482F-A65F-D33541578DC2Q33830995-5B9218F1-B4F5-42FF-9CA5-7A2FAC4E1B08Q34043449-76EDB292-6BE5-4005-B4DD-9C3B94155B2EQ34254472-F4753CFD-BC0F-49E2-8342-26DD4E0648E0Q34311583-B784AEF5-05E5-40EB-A28B-5D3E575D66A5Q34391609-6046E8BD-EE3D-4FD7-B3C5-40D9B6AAC235Q34429362-7357C317-33E8-461D-97F8-5B614BA85AE0Q34555597-FB94CFBC-D99A-4FBF-9652-5CDE5ADD7EE8Q34667249-2CF744DB-91A5-48E4-BA4D-4DF1C5C9EB68Q34974064-EACE5DF0-D6D0-4C02-9617-461746166B8DQ35038084-9CF1BC6B-509E-4D4C-94FD-17E16CE52AC8Q35103708-4D510D5E-12DD-41D0-ABB9-2C31B8754C8DQ35849733-00194425-2446-4554-B613-D0081746F02EQ35882742-01EB46C4-D4FE-4508-8E31-346054899668Q36270003-9E64C6AD-D9FC-4FBF-AB34-C1561B0437F9Q36323864-9318F047-2444-4EA1-8016-169FE2D8CC3DQ36360964-4E193EB2-0036-4B19-92FD-C59B8BF8B885Q36416338-CA16DE7F-63AD-4F6B-B025-10E0E031702FQ36437137-531182A4-CD7A-40FB-B10C-5A2F4AE35B61Q36635154-2802289F-0125-4D95-9FF1-72CA20EAF019Q36693223-4B9A8FC8-8BA7-4DAD-8782-450609201CF4Q36708989-F3D6F6DA-7D96-486C-8E8F-659E588D0F3CQ37046592-594E5ED0-02FF-41A6-92FB-5B1E199D1999Q37203595-63DAEF4C-EDF0-49D8-818A-7FBB42FDC8F0Q37216363-B5A2DA2F-17DB-4920-858E-057A7C3246ABQ37252302-F2D6B5C1-5784-4600-B370-8951FEE36591Q37263146-1D29A26F-9CDA-4D5B-A892-6029EC90327C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Somatic SETBP1 mutations in myeloid malignancies
@en
Somatic SETBP1 mutations in myeloid malignancies.
@nl
type
label
Somatic SETBP1 mutations in myeloid malignancies
@en
Somatic SETBP1 mutations in myeloid malignancies.
@nl
prefLabel
Somatic SETBP1 mutations in myeloid malignancies
@en
Somatic SETBP1 mutations in myeloid malignancies.
@nl
P2093
P2860
P50
P356
P1433
P1476
Somatic SETBP1 mutations in myeloid malignancies
@en
P2093
Andres Jerez
Bartlomiej Przychodzen
Hideki Makishima
Hideki Muramatsu
Hiraku Mori
Hiroko Tanaka
Hirotoshi Sakaguchi
Ines Gomez-Segui
Jaroslaw P Maciejewski
Kathryn Guinta
P2860
P2888
P304
P356
10.1038/NG.2696
P407
P577
2013-07-07T00:00:00Z